Pavel Štourač
- Neurology top 5%
- Peripheral Neuropathies and Disorders 11
- Autoimmune Neurological Disorders and Treatments 4
-
- Multiple Sclerosis Research Studies 28
-
- T-cell and B-cell Immunology 5
- Immunotherapy and Immune Responses 4
-
- Peripheral Neuropathies and Disorders 11
- Autoimmune Neurological Disorders and Treatments 4
-
- Rheumatoid Arthritis Research and Therapies 5
- Systemic Lupus Erythematosus Research 3
-
- Polyomavirus and related diseases 7
Pavel Štourač
43 papers receiving 619 citations
Peers
Comparison fields: 5 of 79
- Neurology 229
- Pathology and Forensic Medicine 233
- Immunology 149
- Neurology 44
- Rheumatology 70
Countries citing papers authored by Pavel Štourač
This map shows the geographic impact of Pavel Štourač's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pavel Štourač with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pavel Štourač more than expected).
Fields of papers citing papers by Pavel Štourač
This network shows the impact of papers produced by Pavel Štourač. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pavel Štourač. The network helps show where Pavel Štourač may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pavel Štourač, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 13 | |
| 3 | 2021 | 2 | |
| 4 | 2021 | 2 | |
| 5 | 2021 | 4 | |
| 6 | 2020 | 17 | |
| 7 | 2020 | 4 | |
| 8 | 2018 | 16 | |
| 9 | 2018 | 0 | |
| 10 | 2016 | 12 | |
| 11 | 2015 | 2 | |
| 12 | [Analgesia for labour in the Czech Republic in the year 2011 from the perspective of OBAAMA-CZ study - prospective national survey]. | 2015 | 6 |
| 13 | Imunomodulační léčba roztroušené sklerózy mozkomíšní vklinických a zobrazovacích parametrech | 2012 | 0 |
| 14 | Algoritmus vyšetření likvoru v návaznosti na doporučení Sekce neuroimunologie a likvorologie České neurologické společnosti JEP | 2012 | 1 |
| 15 | Glatiramer acetát (Copaxone) v léčbě atakovité formyroztroušené sklerózy mozkomíšní – klinická účinnost abezpečnostní profil | 2011 | 0 |
| 16 | Význam cytologie mozkomíšního moku v diagnostice nádorových onemocnění nervového systému | 2009 | 0 |
| 17 | 2009 | 19 | |
| 18 | Tau-protein, fosforylovaný tau-protein a beta-amyloid42 vlikvoru u demencí a roztroušené sklerózy | 2008 | 0 |
| 19 | 2008 | 28 | |
| 20 | 2005 | 38 |
About Pavel Štourač
Pavel Štourač is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology, having authored 54 papers that have together received 645 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (28 papers), Peripheral Neuropathies and Disorders (11 papers), Polyomavirus and related diseases (7 papers), T-cell and B-cell Immunology (5 papers), Rheumatoid Arthritis Research and Therapies (5 papers), Immunotherapy and Immune Responses (4 papers), Autoimmune Neurological Disorders and Treatments (4 papers) and Systemic Lupus Erythematosus Research (3 papers). The work is most often cited by research in Neurology (229 citations), Pathology and Forensic Medicine (233 citations) and Immunology (149 citations). Pavel Štourač has collaborated with scholars based in Czechia, Germany and Austria. Frequent co-authors include Josef Bednařík, Jaroslav Michálek, Zuzana Mikulková, Anna Vašků, Zdeněk Kadaňka, Francesc Graus, Jordi Bruna, Jana Bednářová, Hana Novotná and P. Adam. Their work appears in journals such as Multiple Sclerosis and Related Disorders, Frontiers in Neurology, Journal of the Neurological Sciences, Journal of Neuroimmunology and Neurological Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.